Natalia Grot

Ms. Natalia Grot

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 December 2022 in Genes
Verified
Journal Article
Open access
PDF file
SHSzymon Hryhorowicz
Szymon Hryhorowicz
MKMarta Kaczmarek-Ryś
Marta Kaczmarek-Ryś
ELEmilia Lis-Tanaś
Emilia Lis-Tanaś
JPJakub Porowski
Jakub Porowski
MSMarcin Szuman
Marcin Szuman
APAndrzej Pławski
Andrzej Pławski
Cancer is one of the most common causes of death worldwide. A strong predisposition to cancer is generally only observed in colorectal cancer (5% of cases) and breast cancer (2% of cases). Colorectal cancer is the most common cancer with a strong genetic predisposition, but it includes dozens of various syndromes. This group includes familial adenomatous polyposis, attenuated familial adenomatous polyposis, MUTYH-associated polyposis, NTHL1-associated polyposis, Peutz–Jeghers syndrome, juvenile polyposis syndrome, Cowden syndrome, Lynch syndrome, and Muir–Torre syndrome. The common symptom of all these diseases is a very high risk of colorectal cancer, but depending on the condition, their course is different in terms of age and range of cancer occurrence. The rate of cancer development is determined by its conditioning genes, too. Hereditary predispositions to cancer of the intestine are a group of symptoms of heterogeneous diseases, and their proper diagnosis is crucial for the appropriate management of patients and their successful treatment. Mutations of specific genes cause strong colorectal cancer predispositions. Identifying mutations of predisposing genes will support proper diagnosis and application of appropriate screening programs to avoid malignant neoplasm.

9 April 2022 in Journal of Applied Genetics
Verified
Journal Article
Closed access
PDF file
ABAvishak Barua
Avishak Barua
NGNatalia Grot
Natalia Grot
APAndrzej Pławski
Andrzej Pławski

Verified
Journal Article
Open access
PDF file
NGNatalia Grot
Natalia Grot
MKMarta Kaczmarek-Ryś
Marta Kaczmarek-Ryś
ELEmilia Lis-Tanaś
Emilia Lis-Tanaś
AKAlicja Kryszczyńska
Alicja Kryszczyńska
DNDorota Nowakowska
Dorota Nowakowska
APAndrzej Pławski
Andrzej Pławski
Multiple polyposes are heterogeneous diseases with different underlying molecular backgrounds, sharing a common symptom: the presence of transforming into cancerous intestinal polyps. Recent reports have indicated biallelic mutations in the NTHL1 gene, which is involved in base excision repair (BER), as predisposing to an elevated risk of colorectal cancer (CRC). We aimed to evaluate the significance of the p.Q82* truncating variant in predisposition to intestinal polyposis by assessing its frequency in polyposis patients. We genotyped 644 Polish patients and 634 control DNA samples using high-resolution melting analysis (HRM) and Sanger sequencing. We found the p.Q82* variant in four polyposis patients; in three, it was homozygous (OR = 6.90, p value = 0.202). Moreover, the p.R92C mutation was detected in one patient. We also looked more closely at the disease course in patients carrying NTHL1 mutations. Two homozygous patients also presented other neoplasia. In the family case, we noticed the earlier presence of polyps in the proband and early hepatoblastoma in his brother. We cannot univocally confirm the relationship of p.Q82* with an increased risk of CRC. However, homozygous p.Q82* was more frequent by 10-fold in patients without other mutations identified, which makes NTHL1 gene screening in this group reasonable.

Verified
Journal Article
Open access
PDF file
MSMarcin Szuman
Marcin Szuman
MKMarta Kaczmarek-Ryś
Marta Kaczmarek-Ryś
SHSzymon Hryhorowicz
Szymon Hryhorowicz
AKAlicja Kryszczyńska
Alicja Kryszczyńska
NGNatalia Grot
Natalia Grot
APAndrzej Pławski
Andrzej Pławski
Colorectal cancer (CRC) is one of the most frequent and mortality-causing neoplasia, with various distributions between populations. Strong hereditary predispositions are the causatives of a small percentage of CRC, and most cases have no transparent genetic background. This is a vast arena for exploring cancer low-susceptibility genetic variants. Nonetheless, the research that has been conducted to date has failed to deliver consistent conclusions and often features conflicting messages, causing chaos in this field. Therefore, we decided to organize the existing knowledge on this topic. We screened the PubMed and Google Scholar databases. We drew up markers by gene locus gathered by hallmark: oncogenes, tumor suppressor genes, genes involved in DNA damage repair, genes involved in metabolic pathways, genes involved in methylation, genes that modify the colonic microenvironment, and genes involved in the immune response. Low-penetration genetic variants increasing the risk of cancer are often population-specific, hence the urgent need for large-scale testing. Such endeavors can be successful only when financial decision-makers are united with social educators, medical specialists, genetic consultants, and the scientific community. Countries’ policies should prioritize research on this subject regardless of cost because it is the best investment. In this review, we listed potential low-penetrance CRC susceptibility alleles whose role remains to be established.